Article Information
History
- June 16, 2020.
Article Versions
- You are currently viewing Version 1 of this article (June 16, 2020 - 11:36).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Shaohua Tang1,#,
- Rui Sun2,3,#,
- Qi Xiao2,3,#,
- Tingting Mao1,#,
- Weigang Ge2,3,#,
- Chongquan Huang1,#,
- Meng Luo2,3,4,
- Liujia Qian2,3,
- Hao Chen2,3,
- Qiushi Zhang2,3,
- Sainan Li2,3,
- Wei Liu2,3,5,
- Shufei Li1,
- Xueqin Xu1,
- Huanzheng Li1,
- Lianpeng Wu1,
- Jianyi Dai1,
- Huanhuan Gao2,3,
- Lu Li2,3,
- Tian Lu2,3,
- Xiao Liang2,3,
- Xue Cai2,3,
- Guan Ruan2,3,
- Kexin Liu4,
- Fei Xu5,
- Yan Li6,
- Yi Zhu2,3,*,
- Jianping Huang1,* and
- Tiannan Guo2,3,7,*
- 1Wenzhou Central Hospital, Dingli Clinical Medical School of Wenzhou Medical University, Wenzhou, 325000, Zhejiang, China
- 2Key Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences, Westlake University, 18 Shilongshan Road, Hangzhou 310024, Zhejiang Province, China
- 3Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, 18 Shilongshan Road, Hangzhou 310024, Zhejiang Province, China
- 4Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian 200335, Liaoning, China
- 5Department of Anatomy, College of Basic Medical, Dalian Medical University, Dalian, China
- 6Department of Anatomy and Physiology, College of Basic Medical Sciences, Shanghai Jiao Tong University, No.280 Chongqing South Road, Shanghai 200025, China
- ↵*Correspondence: zhuyi{at}westlake.edu.cn (Y.Z.); hjpzxyy006{at}163.com (J.H.); guotiannan{at}westlake.edu.cn (T.G.)
↵# These authors contribute equally
Posted June 16, 2020.
Proteomics Uncovers Immunosuppression in COVID-19 Patients with Long Disease Course
